F. Lee

发表

Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD

J. Difede, Melissa F Peskin, K. Wyka, 2016, The Journal of nervous and mental disease.

Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer

B. Rothbaum, J. Difede, C. Glatt, 2022, Translational Psychiatry.

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.

Cheri A. Levinson, A. Guastella, K. Ressler, 2019, Journal of anxiety disorders.

Variant brain‐derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder

B. Casey, J. Difede, K. Bath, 2010, Annals of the New York Academy of Sciences.

Treatments for common psychiatric conditions among adults during acute, rehabilitation, and reintegration phases

J. Difede, R. Yurt, Judith Cukor, 2009, International review of psychiatry.

The relationship between posttraumatic and depressive symptoms during virtual reality exposure therapy with a cognitive enhancer.

Katarzyna Wyka, JoAnn Difede, Melissa Peskin, 2019, Journal of anxiety disorders.

Developmental regulation of fear learning and anxiety behavior by endocannabinoids

F. Lee, M. Hill, F. Lee, 2016, Genes, brain, and behavior.

Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder (PTSD): Study protocol for a randomized controlled trial.

B. Rothbaum, A. Rizzo, J. Difede, 2019, Contemporary clinical trials.

D-Cycloserine Augmentation of Exposure Therapy for Post-Traumatic Stress Disorder: A Pilot Randomized Clinical Trial

H. Hoffman, J. Difede, K. Wyka, 2014, Neuropsychopharmacology.

Towards a youth mental health paradigm: a perspective and roadmap.

I. Hickie, T. Paus, M. Keshavan, 2023, Molecular psychiatry.